These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16752501)

  • 1. [Ovarian cancer prognosis and expression of receptors to sex hormones and proliferative activity of tumor cells].
    Novichkov EV; Votintsev AA
    Arkh Patol; 2006; 68(2):10-3. PubMed ID: 16752501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphometrical and immunohistochemical criteria of prognosis in patients with serous and mucinous ovarian carcinoma].
    Kolosov AE; Novichkov EV
    Arkh Patol; 2003; 65(5):29-32. PubMed ID: 14664145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
    Liu JF; Hirsch MS; Lee H; Matulonis UA
    Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.
    Karaferic A; Jovanovic D; Jelic S
    J BUON; 2009; 14(4):635-9. PubMed ID: 20148455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
    Wong KK; Lu KH; Malpica A; Bodurka DC; Shvartsman HS; Schmandt RE; Thornton AD; Deavers MT; Silva EG; Gershenson DM
    Int J Gynecol Pathol; 2007 Oct; 26(4):404-9. PubMed ID: 17885490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary.
    Geisler JP; Wiemann MC; Miller GA; Geisler HE
    Gynecol Oncol; 1996 Mar; 60(3):424-7. PubMed ID: 8774651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma.
    Giles JR; Shivaprasad HL; Johnson PA
    Gynecol Oncol; 2004 Dec; 95(3):530-3. PubMed ID: 15581958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survival.
    Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis B; Agnantis NJ
    Anticancer Res; 2004; 24(3a):1665-70. PubMed ID: 15274338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of laminin-5 in serous adenocarcinomas of the ovary.
    Kohlberger P; Muller-Klingspor V; Heinzl H; Obermair A; Breitenecker G; Leodolter S
    Anticancer Res; 2002; 22(6B):3541-4. PubMed ID: 12552953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers.
    Buchynska LG; Iurchenko NP; Grinkevych VM; Nesina IP; Chekhun SV; Svintsitsky VS
    Exp Oncol; 2009 Mar; 31(1):48-51. PubMed ID: 19300417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of heat shock protein-70, estrogen receptor and progesterone receptor in ovarian carcinomas and the correlation between HSP70 and sex steroid receptor].
    Xing Y; Tang Z; Liao Y; Zhu SF; Li ZM; Chen ML
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):486-8. PubMed ID: 15291106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer.
    Lee P; Rosen DG; Zhu C; Silva EG; Liu J
    Gynecol Oncol; 2005 Mar; 96(3):671-7. PubMed ID: 15721410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients.
    Yang XY; Xi MR; Yang KX; Yu H
    Gynecol Oncol; 2009 Apr; 113(1):99-104. PubMed ID: 19178934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
    De Sousa Damião R; Fujiyama Oshima CT; Stávale JN; Gonçalves WJ
    Oncol Rep; 2007 Jul; 18(1):25-32. PubMed ID: 17549341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
    Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
    Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer.
    Brustmann H
    Pathol Res Pract; 2006; 202(10):713-20. PubMed ID: 16962250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma.
    Wang X; Wei Z; Gao F; Zhang X; Zhou C; Zhu F; Wang Q; Gao Q; Ma C; Sun W; Kong B; Zhang L
    Anticancer Res; 2008; 28(5B):2991-6. PubMed ID: 19031945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.